Growth Hormone Deficiency: What an IGF-1 Blood Test Can Tell You
Clinical review pending
How IGF-1 and IGFBP-3 help investigate growth hormone deficiency, what affects the results and why one blood test cannot make the diagnosis.
Growth hormone deficiency and its blood markers
Growth hormone, also called GH or somatotropin, is made in the front part of the pituitary gland. It enters the bloodstream in short bursts and is cleared quickly. A single GH measurement can fall between those bursts and look low even when there is no deficiency.
More stable signals can help with the investigation. The main one is insulin-like growth factor 1, or IGF-1. Its binding protein, IGFBP-3, can also be useful, particularly in children. The liver produces much of the circulating IGF-1 in response to GH. IGFBP-3 and the acid-labile subunit, ALS, help carry it through the blood. These markers offer a longer-term, though indirect, view of GH activity.
Testing can answer a specific medical question, such as why a child is growing unusually slowly or whether a known pituitary condition has affected hormone production. It can also help monitor an established diagnosis and its treatment. It is not a general test of fitness, recovery or healthy aging.
Why IGF-1 can tell you more than a single GH measurement
IGF-1 varies less over short periods than GH. Results are interpreted using age-related and, where applicable, sex-related reference ranges or a Z-score. Puberty and older adulthood have very different expected levels. The middle of a reference range is not a universal treatment target for healthy people.
A result that is low for your age can support a suspicion of growth hormone deficiency. Poor nutrition, liver disease and other factors can also lower it. Conversely, a normal IGF-1 result does not rule out GH deficiency in adults. When there is a sound reason to suspect it, stimulation testing is often needed. An endocrinologist selects and interprets these tests. The Endocrine Society guideline explains this diagnostic limitation.
In adults, substantial GH deficiency can be associated with less muscle, more abdominal fat, reduced exercise capacity, unfavorable blood lipids and lower bone density. Fatigue alone, however, is very nonspecific. In children, slow growth in height and delayed bone maturation are more prominent clues.
High results need context too. During pregnancy, placental GH and rising IGF-1 change normal physiology. Outside that setting, persistently raised IGF-1 may prompt an investigation for excess GH. Changes in the hands or feet, headaches and sleep apnea can be relevant. One abnormal result does not establish that diagnosis either.
What a blood test cannot tell you
The GH–IGF-1 system influences growth, body composition, bone metabolism and other metabolic processes. Its blood markers cannot directly measure how well individual tissues are repairing themselves or how resilient your immune system is. A result within range is not an all-purpose certificate of good health.
Nutrition, thyroid and liver function, acute illness and medicines can affect the result. Kidney disease also changes binding proteins and hormone activity, so there is no simple rule that IGF-1 must always be low. Laboratories may use different methods and reference ranges.
Symptoms, growth or physical development, medical history and sometimes other pituitary hormones therefore need to be considered together. Finding low or borderline IGF-1 while investigating tiredness does not, by itself, explain the tiredness or establish a reason to start GH treatment.
Frequently asked questions
What does blood testing for suspected GH deficiency measure?
The investigation usually begins with IGF-1, an indirect marker of GH activity. IGFBP-3 may be added in children. A random GH measurement has limited value because release is pulsatile. Depending on the findings, a supervised stimulation test may follow.
When might testing be useful?
Examples include an unusual growth pattern, a known pituitary disorder or a relevant treatment history. Low bone density, changes in body composition and fatigue may matter in that context, but do not prove deficiency on their own. That is different from routinely testing everyone who feels low on energy.
Can the blood sample be taken at home?
A properly arranged venous blood draw can take place at home. What matters is a suitable laboratory, correct sample handling and clinical interpretation. Where the sample is collected does not turn IGF-1 into a complete test of pituitary function.
How often should IGF-1 be checked?
That depends on the reason for testing. Regular repeats are usually not useful without new symptoms or a treatment-related reason. During GH treatment, monitoring is adjusted around dose changes and progress. Benefits and side effects matter alongside the laboratory number.
What can affect the result?
Age, puberty, pregnancy, nutrition, acute or chronic illness, and thyroid, liver and kidney function all matter. Poorly controlled diabetes and medicines such as oral estrogens or glucocorticoids can also affect this hormonal system. Obesity can alter GH release and stimulation-test responses without a corresponding fall in IGF-1.
Do I need to fast before the blood draw?
Fasting is often unnecessary for IGF-1 alone, but other tests taken at the same time may have different requirements. Follow the laboratory’s instructions. High-dose biotin can interfere with some testing methods. Tell the team which product and dose you take so that any pause can be matched to the assay. Do not stop prescribed medicines on your own.
Can lifestyle change the result?
Yes. A substantial shortage of calories or protein can lower IGF-1. Sleep, physical exertion and metabolic health also play a role. This does not mean that raising IGF-1 as high as possible with supplements or hormones is beneficial. The useful goal is to address a real nutritional shortfall or illness.
How should I read my report?
Use the testing laboratory’s reference range and consider your age, medicines and health circumstances. Low results can support a suspicion; normal results cannot reliably exclude deficiency. When findings conflict, a specialist considers the full picture before deciding whether more testing is needed.
Sources and scope
The references below include adult GH-deficiency guidelines, an assay-standardization consensus statement and public health information. Their identities and the main diagnostic limitations were checked for this translation. This focused review is separate from independent clinical review and is not an exhaustive search for every subsequent guideline update.